Want to see SE:CANTA full AI Analyst Report?
Cantargia AB (CANTA) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Can10 | Healthy, Plaque Psoriasis | Phase I | Recruiting | A Study to Investigate the Safety and Tolerability of CAN10 Antibody in Healthy Subjects and in Subjects With Plaque Psoriasis. | Nov 16, 2023 | ― |
| Carboplatin, Gemcitabine, Nadunolimab | Triple Negative Breast Cancer | phase1AndPhase2 | Active Not Recruiting | Nadunolimab in Combination with Gemcitabine Plus Carboplatin in Patients with Advanced Triple Negative Breast Cancer. | Dec 01, 2021 | ― |
| Can04 (Nadunolimab), Mfolfox, Dtx, G/C | Colorectal Cancer, Biliary Tract Cancer, Non Small Cell Lung Cancer, Advanced Solid Tumors | phase1AndPhase2 | Completed | A Phase 1/2 Study of CAN04 in Combination With Different Chemotherapy Regimens in Subjects With Advanced Solid Tumors | Oct 07, 2021 | ― |
| Can04, Folfirinox | Metastatic Pancreatic Ductal Adenocarcinoma | Phase I | Completed | A Study of the Safety and Tolerance of CAN04 in Combination With FOLFIRINOX in Subjects With Metastatic Pancreatic Ductal Adenocarcinoma | Jun 21, 2021 | ― |
| Carboplatin, Pembrolizumab, Pemetrexed, Can04 | Carcinoma, Non-small-cell Lung, Head And Neck Squamous Cell Carcinoma, Malignant Melanoma, Urothelial Carcinoma | Phase I | Completed | A Study of the Safety and Tolerance of CAN04 and Pembrolizumab in Combination With and Without Carboplatin and Pemetrexed in Subjects With Solid Tumors | Jun 24, 2020 | ― |
| Carboplatin, Gemcitabine, Cisplatin, Nab-paclitaxel, Pemetrexed, Can04 | Colorectal Cancer, Non Small Cell Lung Cancer, Triple Negative Breast Cancer, Pancreatic Ductal Adenocarcinoma | phase1AndPhase2 | Completed | A First-in-Human Study of CAN04 in Patients With Solid Malignant Tumors | Aug 24, 2017 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Can10 | Phase I | Healthy, Plaque Psoriasis | Recruiting | A Study to Investigate the Safety and Tolerability of CAN10 Antibody in Healthy Subjects and in Subjects With Plaque Psoriasis. | Nov 16, 2023 | ― |
| Carboplatin, Gemcitabine, Nadunolimab | phase1AndPhase2 | Triple Negative Breast Cancer | Active Not Recruiting | Nadunolimab in Combination with Gemcitabine Plus Carboplatin in Patients with Advanced Triple Negative Breast Cancer. | Dec 01, 2021 | ― |
| Can04 (Nadunolimab), Mfolfox, Dtx, G/C | phase1AndPhase2 | Colorectal Cancer, Biliary Tract Cancer, Non Small Cell Lung Cancer, Advanced Solid Tumors | Completed | A Phase 1/2 Study of CAN04 in Combination With Different Chemotherapy Regimens in Subjects With Advanced Solid Tumors | Oct 07, 2021 | ― |
| Can04, Folfirinox | Phase I | Metastatic Pancreatic Ductal Adenocarcinoma | Completed | A Study of the Safety and Tolerance of CAN04 in Combination With FOLFIRINOX in Subjects With Metastatic Pancreatic Ductal Adenocarcinoma | Jun 21, 2021 | ― |
| Carboplatin, Pembrolizumab, Pemetrexed, Can04 | Phase I | Carcinoma, Non-small-cell Lung, Head And Neck Squamous Cell Carcinoma, Malignant Melanoma, Urothelial Carcinoma | Completed | A Study of the Safety and Tolerance of CAN04 and Pembrolizumab in Combination With and Without Carboplatin and Pemetrexed in Subjects With Solid Tumors | Jun 24, 2020 | ― |
| Carboplatin, Gemcitabine, Cisplatin, Nab-paclitaxel, Pemetrexed, Can04 | phase1AndPhase2 | Colorectal Cancer, Non Small Cell Lung Cancer, Triple Negative Breast Cancer, Pancreatic Ductal Adenocarcinoma | Completed | A First-in-Human Study of CAN04 in Patients With Solid Malignant Tumors | Aug 24, 2017 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Cantargia AB (SE:CANTA) have in its pipeline
Cantargia AB SE:CANTA is currently developing the following drugs: Can10, Carboplatin, Gemcitabine, Nadunolimab, Can04 (Nadunolimab), Mfolfox, Dtx, G/C, Can04, Folfirinox, Carboplatin, Pembrolizumab, Pemetrexed, Can04, Carboplatin, Gemcitabine, Cisplatin, Nab-paclitaxel, Pemetrexed, Can04. These drug candidates are in various stages of clinical development as the company works toward FDA approval.